Product information

IUPAC  5-([(2-aminoacetyl)amino]methyl)-1-[4-chloro-2-(2-chlorobenzoyl)phenyl] -N,N-dimethyl-1,2,4-triazole-3-carboxamide

Synonyms  Rilmazafone, Rhythmy

CAS        99593-25-6

Formula     C₂₁H₂₀Cl₂N₆O₃

Molecular Weight   475.33

Purity     99.0 % min.

Formulations    A neat solid, Powder, Pills (2mg)

Rilmazafone, Rhythmy

Rhythmy is a water-soluble prodrug produced in Japan. Once converted to a class of drugs known as rilmazazepine, it has sedative and hypnotic properties. These compounds can cause impairment of motor function and are capable of inducing hypnosis.

Although rilmazafone is a derivative of rilmazazepine, it is not a benzodiazepine. This is because its parent drug does not have a diazepine ring. This means that it is not a controlled substance in the US and other countries.

Although rilmazafone does not have psychoactive effects, it can still be used as a drug for treating anxiety and depression. It is also used to treat other conditions. Once it reaches the body, it is broken down by enzymes in the small intestine. These compounds are then used to form the active ingredients of a class of drugs known as benzodiazepine.

The main metabolite of rilmazafone is composed of a type of benzene ring that is fused with a diazepine ring. This is different from the parent compound, which does not have a diazepine ring.

The toxicological and physiological properties of this compound has not been analyzed. Usage of this Chemical should be for research and forensic purposes only.

WARNING This product is not for human or veterinary use.

This product is only available to persons of 21 years old and above.

Hazard statement(s)